Inulin supplementation lowered the metabolic defects of prolonged exposure to chlorpyrifos from gestation to young adult stage in offspring rats

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Reygner, Julie ^a,b   Lichtenberger, Lydia ^b   Elmhiri, Ghada ^a   Dou, Samir ^a   Bahi Jaber, Narges ^a   Rhazi, Larbi ^a   Depeint, Flore ^a   Bach, Veronique ^b   Khorsi Cauet, Hafida ^b   Abdennebi Najar, Latifa ^a  

^a INSTITUT POLYTECHNIQUE LASALLE BEAUVAIS   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CHLORPYRIFOS; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR BETA; INULIN; LEPTIN; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FEMALE; FERMENTATION; GESTATION PERIOD; HYPERINSULINEMIA; INTESTINE FLORA; LONG TERM EXPOSURE; MALE; METABOLIC DISORDER; NONHUMAN; PERINATAL PERIOD; PROGENY; RAT; ANIMAL; BODY WEIGHT; DIETARY SUPPLEMENT; DRINKING; DRUG EFFECT; DRUG THERAPY; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECT; TIME FACTOR; WISTAR RAT;

ANIMALS; BODY WEIGHT; CHLORPYRIFOS; DIETARY SUPPLEMENTS; DRINKING; FEMALE; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION REGULATION; GROWTH AND DEVELOPMENT; INSULIN; INULIN; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR; TIME FACTORS;

EID: 84992077605     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164614     Document Type: Article

References (52)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May; 27(5):1047-53. PMID: 15111519
2. Jaacks LM, Staimez LR. Association of persistent organic pollutants and non-persistent pesticides with diabetes and diabetes-related health outcomes in Asia: A systematic review. Environ Int. 2015 Mar; 76:57-70. doi: 10.1016/j.envint.2014.12.001 PMID: 25545233
3. Saldana TM, Basso O, Hoppin JA, Baird DD, Knott C, Blair A, et al. Pesticide exposure and selfreported gestational diabetes mellitus in the Agricultural Health Study. Diabetes Care. 2007 Mar; 30 (3):529-34. doi: 10.2337/dc06-1832 PMID: 17327316
4. Taylor KW, Novak RF, Anderson HA, Birnbaum LS, Blystone C, Devito M, et al. Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review. Environ Health Perspect. 2013 Jul; 121(7):774-83. doi: 10.1289/ehp.1205502 PMID: 23651634
5. Thayer KA, Heindel JJ, Bucher JR, Gallo MA. Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environ Health Perspect. 2012 Jun; 120 (6):779-89. doi: 10.1289/ehp.1104597 PMID: 22296744
6. Zhang Y, Han S, Liang D, Shi X, Wang F, Liu W, et al. Prenatal exposure to organophosphate pesticides and neurobehavioral development of neonates: a birth cohort study in Shenyang, China. PloS One. 2014; 9(2):e88491. doi: 10.1371/journal.pone.0088491 PMID: 24551109
7. Saunders M, Magnanti BL, Correia Carreira S, Yang A, Alamo-Hernández U, Riojas-Rodriguez H, et al. Chlorpyrifos and neurodevelopmental effects: a literature review and expert elicitation on research and policy. Environ Health Glob Access Sci Source. 2012; 11 Suppl 1:S5.
8. Kwong TC. Organophosphate pesticides: biochemistry and clinical toxicology. Ther Drug Monit. 2002 Feb; 24(1):144-9. PMID: 11805735
9. Slotkin TA, Brown KK, Seidler FJ. Developmental exposure of rats to chlorpyrifos elicits sex-selective hyperlipidemia and hyperinsulinemia in adulthood. Environ Health Perspect. 2005 Oct; 113(10):1291-4. doi: 10.1289/ehp.8133 PMID: 16203236
10. Slotkin TA. Does early-life exposure to organophosphate insecticides lead to prediabetes and obesity? Reprod Toxicol Elmsford N. 2011 Apr; 31(3):297-301.
11. Barker DJP, Lampl M. Commentary: The meaning of thrift. Int J Epidemiol. 2013 Oct; 42(5):1229-30. doi: 10.1093/ije/dyt131 PMID: 24159068
12. Khan MT, Nieuwdorp M, Bäckhed F. Microbial modulation of insulin sensitivity. Cell Metab. 2014 Nov 4; 20(5):753-60. doi: 10.1016/j.cmet.2014.07.006 PMID: 25176147
13. Hur KY, Lee M-S. Gut Microbiota and Metabolic Disorders. Diabetes Metab J. 2015 Jun; 39(3):198-203. doi: 10.4093/dmj.2015.39.3.198 PMID: 26124989
14. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012 Sep 13; 489(7415):242-9. doi: 10.1038/nature11552 PMID: 22972297
15. Cani PD, Everard A, Duparc T. Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol. 2013 Dec; 13(6):935-40. doi: 10.1016/j.coph.2013.09.008 PMID: 24075718
16. Tomas J, Reygner J, Mayeur C, Ducroc R, Bouet S, Bridonneau C, et al. Early colonizing Escherichia coli elicits remodeling of rat colonic epithelium shifting toward a new homeostatic state. ISME J. 2015 Jan; 9(1):46-58. doi: 10.1038/ismej.2014.111 PMID: 25012905
17. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007 Jul; 56(7):1761-72. doi: 10.2337/db06-1491 PMID: 17456850
18. Larsen N, Vogensen FK, van den Berg FWJ, Nielsen DS, Andreasen AS, Pedersen BK, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS One. 2010; 5(2): e9085. doi: 10.1371/journal.pone.0009085 PMID: 20140211
19. Cani PD, Joly E, Horsmans Y, Delzenne NM. Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr. 2006 May; 60(5):567-72. doi: 10.1038/sj.ejcn.1602350 PMID: 16340949
20. Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des. 2009; 15(13):1546-58. PMID: 19442172
21. Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Muccioli GM, et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes. 2011 Nov; 60(11):2775-86. doi: 10.2337/db11-0227 PMID: 21933985
22. Byrne CS, Chambers ES, Morrison DJ, Frost G. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int J Obes 2005. 2015 Sep; 39(9):1331-8.
23. Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol. 2013 Feb; 27(1):73-83. doi: 10.1016/j.bpg.2013.03.007 PMID: 23768554
24. Geurts L, Neyrinck AM, Delzenne NM, Knauf C, Cani PD. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef Microbes. 2014 Mar; 5(1):3-17. doi: 10.3920/BM2012.0065 PMID: 23886976
25. Joly Condette C, Bach V, Mayeur C, Gay-Quéheillard J, Khorsi-Cauet H. Chlorpyrifos Exposure During Perinatal Period Affects Intestinal Microbiota Associated With Delay of Maturation of Digestive Tract in Rats. J Pediatr Gastroenterol Nutr. 2015 Jul; 61(1):30-40. doi: 10.1097/MPG.0000000000000734 PMID: 25643018
26. Elmhiri G, Barella LF, Vieau D, Camous S, Mathias PCF, Abdennebi-Najar L. Acute exposure to a precursor of advanced glycation end products induces a dual effect on the rat pancreatic islet function. Int J Endocrinol. 2014; 2014:378284. doi: 10.1155/2014/378284 PMID: 25484898
27. Abdennebi-Najar L, Desai M, Han G, Casillas E, Jean D, Arieh G, et al. Basal, endogenous leptin is metabolically active in newborn rat pups. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2011 Dec; 24(12):1486-91.
28. Mayeur C, Gratadoux J-J, Bridonneau C, Chegdani F, Larroque B, Kapel N, et al. Faecal D/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome. PloS One. 2013; 8(1):e54335. doi: 10.1371/journal.pone.0054335 PMID: 23372709
29. Ettreiki C, Gadonna-Widehem P, Mangin I, Coë ffier M, Delayre-Orthez C, Anton PM. Juvenile ferric iron prevents microbiota dysbiosis and colitis in adult rodents. World J Gastroenterol. 2012 Jun 7; 18 (21):2619-29. doi: 10.3748/wjg.v18.i21.2619 PMID: 22690070
30. Lecerf J-M, Dépeint F, Clerc E, Dugenet Y, Niamba CN, Rhazi L, et al. Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr. 2012 Nov 28; 108(10):1847-58. doi: 10.1017/S0007114511007252 PMID: 22264499
31. Firmin S, Bahi-Jaber N, Abdennebi-Najar L. Food contaminants and programming of type 2 diabetes: recent findings from animal studies. J Dev Orig Health Dis. 2016 Jun 13;1-8.
32. Barker DJP. The developmental origins of insulin resistance. Horm Res. 2005; 64 Suppl 3:2-7. doi: 10. 1159/000089311 PMID: 16439838
33. Lassiter TL, Ryde IT, Mackillop EA, Brown KK, Levin ED, Seidler FJ, et al. Exposure of neonatal rats to parathion elicits sex-selective reprogramming of metabolism and alters the response to a high-fat diet in adulthood. Environ Health Perspect. 2008 Nov; 116(11):1456-62. doi: 10.1289/ehp.11673 PMID: 19057696
34. Lassiter TL, Barone S, Padilla S. Ontogenetic differences in the regional and cellular acetylcholinesterase and butyrylcholinesterase activity in the rat brain. Brain Res Dev Brain Res. 1998 Jan 14; 105 (1):109-23.
35. Mansour SA, Mossa A-TH. Adverse effects of exposure to low doses of chlorpyrifos in lactating rats. Toxicol Ind Health. 2011 Apr; 27(3):213-24. doi: 10.1177/0748233710384054 PMID: 20870695
36. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001 Dec 13; 414(6865):799-806. doi: 10.1038/414799a PMID: 11742412
37. Meggs WJ, Brewer KL. Weight gain associated with chronic exposure to chlorpyrifos in rats. J Med Toxicol Off J Am Coll Med Toxicol. 2007 Sep; 3(3):89-93.
38. Tanvir EM, Afroz R, Chowdhury M, Gan SH, Karim N, Islam MN, et al. A model of chlorpyrifos distribution and its biochemical effects on the liver and kidneys of rats. Hum Exp Toxicol. 2015 Oct 30
39. Joly Condette C, Khorsi-Cauet H, Morlière P, Zabijak L, Reygner J, Bach V, et al. Increased gut permeability and bacterial translocation after chronic chlorpyrifos exposure in rats. PloS One. 2014; 9(7): e102217. doi: 10.1371/journal.pone.0102217 PMID: 25019507
40. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell. 2000 Jul; 6(1):87-97. PMID: 10949030
41. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr. 2010 Aug; 104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363 PMID: 20920376
42. Van de Wiele T, Boon N, Possemiers S, Jacobs H, Verstraete W. Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J Appl Microbiol. 2007 Feb; 102 (2):452-60. doi: 10.1111/j.1365-2672.2006.03084.x PMID: 17241351
43. Scott KP, Martin JC, Duncan SH, Flint HJ. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiol Ecol. 2014 Jan; 87(1):30-40. doi: 10.1111/1574-6941.12186 PMID: 23909466
44. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr. 2009 Feb; 101(4):541-50. doi: 10.1017/S0007114508019880 PMID: 18590586
45. Campbell JM, Fahey GC, Wolf BW. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr. 1997 Jan; 127(1):130-6. PMID: 9040556
46. Weitkunat K, Schumann S, Petzke KJ, Blaut M, Loh G, Klaus S. Effects of dietary inulin on bacterial growth, short-chain fatty acid production and hepatic lipid metabolism in gnotobiotic mice. J Nutr Biochem. 2015 Sep; 26(9):929-37. doi: 10.1016/j.jnutbio.2015.03.010 PMID: 26033744
47. Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. 2013; 4:1829. doi: 10.1038/ncomms2852 PMID: 23652017
48. Louis P, Scott KP, Duncan SH, Flint HJ. Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol. 2007 May; 102(5):1197-208. doi: 10.1111/j.1365-2672.2007. 03322.x PMID: 17448155
49. Duncan SH, Holtrop G, Lobley GE, Calder AG, Stewart CS, Flint HJ. Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr. 2004 Jun; 91(6):915-23. doi: 10.1079/BJN20041150 PMID: 15182395
50. Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013 Jun 6; 498 (7452):99-103. doi: 10.1038/nature12198 PMID: 23719380
51. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012 Oct 4; 490(7418):55-60. doi: 10.1038/nature11450 PMID: 23023125
52. Wu X, Ma C, Han L, Nawaz M, Gao F, Zhang X, et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol. 2010 Jul; 61(1):69-78. doi: 10.1007/s00284-010-9582-9 PMID: 20087741